Selected article for: "antiviral effect and broad spectrum antiviral"

Author: Cao, Rui-Yuan; Xu, Yong-fen; Zhang, Tian-Hong; Yang, Jing-Jing; Yuan, Ye; Hao, Pei; Shi, Yi; Zhong, Jin; Zhong, Wu
Title: Pediatric Drug Nitazoxanide: A Potential Choice for Control of Zika
  • Document date: 2017_2_3
  • ID: sbf9qi6g_3
    Snippet: In this study, we report that the pediatric drug nitazoxanide, which is a broad-spectrum antiviral agent initially approved by the FDA as an antiprotozoan drug and has overwhelming safety due to extensive postmarketing experience involving almost 75 million adults and children [9] , has the potential to inhibit ZIKV infection in vitro, and we identified that it targets the postviral entry step to exert its antiviral effect......
    Document: In this study, we report that the pediatric drug nitazoxanide, which is a broad-spectrum antiviral agent initially approved by the FDA as an antiprotozoan drug and has overwhelming safety due to extensive postmarketing experience involving almost 75 million adults and children [9] , has the potential to inhibit ZIKV infection in vitro, and we identified that it targets the postviral entry step to exert its antiviral effect.

    Search related documents:
    Co phrase search for related documents
    • antiviral agent and entry step: 1, 2
    • antiviral agent and vitro ZIKV infection: 1, 2, 3
    • antiviral agent and vitro ZIKV infection inhibit: 1
    • antiviral agent and ZIKV infection: 1, 2, 3, 4, 5
    • antiviral effect and broad spectrum: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • antiviral effect and entry step: 1, 2, 3, 4, 5
    • antiviral effect and pediatric drug: 1
    • antiviral effect and ZIKV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • antiviral effect exert and broad spectrum: 1, 2, 3
    • antiviral effect exert and entry step: 1, 2
    • antiviral effect exert and ZIKV infection: 1
    • broad spectrum and entry step: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • broad spectrum and pediatric drug: 1
    • broad spectrum and vitro ZIKV infection: 1
    • broad spectrum and vitro ZIKV infection inhibit: 1
    • broad spectrum and ZIKV infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • nitazoxanide pediatric drug and pediatric drug: 1
    • nitazoxanide pediatric drug and ZIKV infection: 1
    • pediatric drug and ZIKV infection: 1, 2